Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Natco Pharma's Q4 net profit falls 22%; shares drop 4%

Consolidated revenue declined marginally by 0.2 percent YoY to Rs 454.8 crore in Q4FY20 against Rs 455.7 crore in Q4FY19.

June 17, 2020 / 05:57 PM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Natco Pharma fell 4.04 percent to close at Rs 613.40 on BSE on June 17 after the company reported a 22 percent fall in its Q4 net profit.

The pharmaceuticals player, on June 17, reported a 22.1 percent year-on-year (YoY) fall in the FY20 March quarter consolidated net profit at Rs 94.1 crore against Rs 120.8 crore in the corresponding quarter of the previous financial year.

Consolidated revenue declined marginally by 0.2 percent YoY to Rs 454.8 crore in Q4FY20 against Rs 455.7 crore in Q4 FY19.

Consolidated EBITDA fell 13.5 percent YoY to Rs 128.3 crore in Q4 FY20 against Rs 148.3 crore in Q4FY19.

The consolidated EBITDA margin came at 28.2 percent against 32.5 percent YoY.

Moneycontrol News
first published: Jun 17, 2020 02:25 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347